Overview

Sevoflurane in Subarachnoidal Haemorrhage

Status:
Withdrawn

Trial end date:
2019-12-31

Target enrollment:

Participant gender:

Summary

Feasibility and safety of short term application of sevoflurane in patients with SAH treated with aneurysm coiling or clipping in the setting of a neurointensive care unit.

Phase:

Phase 2

Details

Lead Sponsor:

University of Zurich

Treatments:

Midazolam
Propofol
Sevoflurane